Diagnosis and Management of Primary Liver Cancers

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 79

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Medical, Oral and Biotechnological Sciences, University “G. d’Annunzio” Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
2. Villa Serena Foundation for Research, 65013 Città Sant’Angelo, Pescara, Italy
Interests: general surgery; endocrine surgery; thyroid diseases; surgical education
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Unit of General Surgery, Ospedale Floraspe Renzetti, 66034 Lanciano, Chieti, Italy
Interests: general surgery; emergency surgery; translational research; surgical education

Special Issue Information

Dear Colleagues,

Primary liver cancers are increasing in incidence and mortality. Unfortunately, the diagnosis of these cancers is often made late due to their silent nature and invasiveness. At present, the understanding of primary liver carcinogenesis is essential to develop more efficient combinations of immune inhibitors and chemotherapies together with surgical and non-surgical strategies.

Improved therapeutic protocols for patients with advanced or metastatic primary liver cancer are currently advocated. For this Special Issue, submissions of clinical and experimental research that focus on the diagnosis and treatment of primary liver cancers with personal experience are invited. Studies designed to clarify the following topics are welcome for submissions: diagnosis and management of cholangiocarcinoma and diagnosis of biliary intraepithelial neoplasm and intraductal papillary neoplasm. In addition, studies on ecoendoscopy and artificial intelligence in the research field of primary liver cancer are strongly encouraged.

Dr. Roberto Cotellese
Dr. Federico Selvaggi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatocellular carcinoma
  • cholangiocarcinoma
  • radiofrequency ablation
  • ecoendoscopy
  • chemotherapy
  • immunotherapy
  • surgery

Published Papers

This special issue is now open for submission.
Back to TopTop